Spots Global Cancer Trial Database for Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy

Official Title: Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy

Study ID: NCT04566302

Conditions

Pigmented Lesions

Pigmented Skin Lesion

Pigmented Moles

Skin Lesion

Interventions

SECM Skin Imaging

Study Description

Brief Summary: The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.

Detailed Description: SECM provides an order of magnitude faster imaging speed than conventional confocal microscopy devices. The investigators have previously utilized the SECM technology for imaging large area of human esophagus in vivo. They have also developed endoscopic capsule devices which have been used to safely image over 60 human subjects, healthy volunteers and subjects with eosinophilic esophagitis, using SECM technology, rapidly. When used for skin imaging, SECM can provide real-time three-dimensional confocal imaging and significantly reduce the imaging time. While SECM has been successfully used for imaging human esophagus in vivo, its utility in skin imaging needs to be tested in a new pilot study. The investigators will be taking images with a dermatoscope as well. This will the control to compare the experimental images to, as the dermatoscope is the standard of care diagnostic tool for dermatologists.